ARTICLE | Company News
Oryx, Novartis deal
September 9, 2002 7:00 AM UTC
Specialty pharma company Oryx acquired Canadian rights to NVS's Anafranil clomipramine to treat depression and obsessive compulsive disorder, and Restoril temazepam for transient and short-term insomn...